Tuesday July 05, 2016

Moorfields Announces Research Partnership With Google's DeepMind

We are excited to announce a new medical research partnership with DeepMind Health that could revolutionise the way professionals carry out eye tests and lead to earlier detection of common eye diseases. Two million people are living with sight loss in the UK, of whom around 360,000 are registered as blind or partially sighted. At the moment, eye health professionals rely on digital scans of the eye to diagnose and determine the correct treatment for common eye conditions such as age-related macular degeneration and diabetic retinopathy. These scans are highly complex and to date, traditional analysis tools have been unable to explore them fully. It also takes eye health professionals a long time to analyse eye scans, which can have an impact on how quickly they can meet patients to discuss diagnosis and treatment.

Our collaboration with Deepmind is investigating how technology could help to analyse eye scans, giving clinicians a better understanding of eye disease. The project will involve Moorfields sharing a set of one million anonymised eye scans with DeepMind, and some related anonymous information about eye condition and disease management, which Moorfields has collected over time through routine care. This means it’s not possible to identify any individual patients from the scans. They’re also historic scans, meaning that while the results of our research may be used to improve future care, they won’t affect the care any of our patients receive today.

Comments